Big Pharma

Big pharma proves that oncology pays as workforces shrink
Big pharma proves that oncology pays as workforces shrink
EP Vantage
oncology
Big Pharma
Flag link:
Big Pharma executives jump to China startups for higher pay and more say: report
Big Pharma executives jump to China startups for higher pay and more say: report
Fierce Pharma
China
Big Pharma
Flag link:
J&J, Pfizer, Merck again lead pharma in Fortune 500
J&J, Pfizer, Merck again lead pharma in Fortune 500
Biopharma Dive
Fortune 500
Big Pharma
JNJ
Merck
Pfizer
Flag link:
Which Big Pharma CEOs Least Deserved Their Big Pay Increases?
Which Big Pharma CEOs Least Deserved Their Big Pay Increases?
Motley Fool
Big Pharma
Pharma CEOs
executive pay
AbbVie
Bristol-Myers Squibb
Gilead Sciences
JNJ
Pfizer
Flag link:
Will flush-with-cash Big Pharma beat Takeda to a Shire deal?
Will flush-with-cash Big Pharma beat Takeda to a Shire deal?
Fierce Pharma
Takeda
Shire
M&A
Big Pharma
Flag link:
Big Pharma's billion-dollar scramble to invest in start-ups to fuel innovation
Big Pharma's billion-dollar scramble to invest in start-ups to fuel innovation
CNBC
Big Pharma
innovation
start-ups
Flag link:
New Budget Deals Big Pharma a Blow on Medicare Part D, but Omeros Scores
New Budget Deals Big Pharma a Blow on Medicare Part D, but Omeros Scores
TheStreet.com
Big Pharma
Medicare Part D
Omeros
Omnibus Bill
Flag link:
Big Pharma's winners and losers last year? AbbVie and AstraZeneca up, GSK down
Big Pharma's winners and losers last year? AbbVie and AstraZeneca up, GSK down
Fierce Pharma
AbbVie
AstraZeneca
GSK
Sanofi
Merck
Big Pharma
Flag link:
Senator questions big pharma buyback strategy
Senator questions big pharma buyback strategy
Biopharma Dive
Big Pharma
Pfizer
Merck
JNJ
AbbVie
Abbott Labs
share repurchase
Flag link:
Big Pharma invests in research for new antibiotics ($2bn)
Big Pharma invests in research for new antibiotics ($2bn)
GoinPharma
Big Pharma
R&D
antibiotics
Flag link:
Why Big Pharma And Biotech Companies Are Girding For A Pricing 'Knife Fight'
Why Big Pharma And Biotech Companies Are Girding For A Pricing 'Knife Fight'
Investors Business Daily
Big Pharma
biotech
drug pricing
generics
Flag link:
Big Pharma R&D is exiting China, but leaving a legacy; China’s biotech execs couldn’t be happier
Big Pharma R&D is exiting China, but leaving a legacy; China’s biotech execs couldn’t be happier
Endpoints
Big Pharma
China
R&D
Flag link:
Deconstructing Drug Pricing Strategy for Big Pharma
Deconstructing Drug Pricing Strategy for Big Pharma
Drug Patent Watch
drug pricing
Big Pharma
consumers
Flag link:
Big Pharma Doesn't Want Health Outcomes To Sway Pricing -- At Least Not Yet
Big Pharma Doesn't Want Health Outcomes To Sway Pricing -- At Least Not Yet
Forbes
Big Pharma
drug pricing
gene therapy
Novartis
Kymriah
Flag link:
Revival of Gilead Whistleblower's Lawsuit Should Stoke Fear In Big Pharma
Revival of Gilead Whistleblower's Lawsuit Should Stoke Fear In Big Pharma
Forbes
Gilead Sciences
whistleblower lawsuits
Big Pharma
drug manufacturing
Flag link:
Women in big pharma boards: still under-represented
Women in big pharma boards: still under-represented
GoInPharma
Big Pharma
women
Flag link:
From big biopharma to biotech CEO, John Houston’s R&D journey highlights a fast-changing world
From big biopharma to biotech CEO, John Houston’s R&D journey highlights a fast-changing world
Endpoints
R&D
John Houston
Big Pharma
biotech
Arvinas
GSK
Bristol-Myers Squibb
Flag link:
Big pharma stands to make hundreds of billions of dollars from a handful of medical conditions
Big pharma stands to make hundreds of billions of dollars from a handful of medical conditions
Motley Fool
Big Pharma
viral hepatitis
respiratory disease
autoimmune disease
cardiovascular disease
pain
diabetes
cancer
Flag link:
Managing Revenue Growth (And Contraction) In Big Pharma: What Have We Learned In The Last 10 Years?
Managing Revenue Growth (And Contraction) In Big Pharma: What Have We Learned In The Last 10 Years?
Forbes
Big Pharma
revenue
Flag link:
Meet Bertrand Bodson, Novartis’ new global digital strategy maestro for all things Big Pharma
Meet Bertrand Bodson, Novartis’ new global digital strategy maestro for all things Big Pharma
Endpoints
Novartis
digital pharma
Big Pharma
Flag link:

Pages